Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis.

Maddur MS, Lacroix-Desmazes S, Dimitrov JD, Kazatchkine MD, Bayry J, Kaveri SV.

Clin Rev Allergy Immunol. 2019 Jun 3. doi: 10.1007/s12016-019-08746-9. [Epub ahead of print] Review.

PMID:
31161341
2.

Wuchereria bancrofti filaria activates human dendritic cells and polarizes T helper 1 and regulatory T cells via toll-like receptor 4.

Mukherjee S, Karnam A, Das M, Babu SPS, Bayry J.

Commun Biol. 2019 May 7;2:169. doi: 10.1038/s42003-019-0392-8. eCollection 2019.

3.

Current trends with FOXP3+ regulatory T cell immunotherapy to contest autoimmunity and inflammation.

Trinath J, Bayry J.

Immunotherapy. 2019 Jun;11(9):755-758. doi: 10.2217/imt-2019-0069. Epub 2019 May 16. No abstract available.

4.

Does intravenous immunoglobulin therapy in Guillain-Barré syndrome patients interfere with serological Zika detection?

Karnam A, Stephen-Victor E, Das M, Magy L, Vallat JM, Bolgert F, Simon-Loriere E, Kaveri SV, Sakuntabhai A, Bayry J.

Autoimmun Rev. 2019 Jun;18(6):632-633. doi: 10.1016/j.autrev.2019.01.004. Epub 2019 Apr 5. No abstract available.

PMID:
30959213
5.

Intravenous immunoglobulin suppresses the polarization of both classically and alternatively activated macrophages.

Saha C, Kothapalli P, Patil V, ManjunathaReddy GB, Kaveri SV, Bayry J.

Hum Vaccin Immunother. 2019 Apr 4:1-7. doi: 10.1080/21645515.2019.1602434. [Epub ahead of print]

PMID:
30945973
6.

Intravenous Immunoglobulin Therapy Eliminates Candida albicans and Maintains Intestinal Homeostasis in a Murine Model of Dextran Sulfate Sodium-Induced Colitis.

Charlet R, Sendid B, Kaveri SV, Poulain D, Bayry J, Jawhara S.

Int J Mol Sci. 2019 Mar 23;20(6). pii: E1473. doi: 10.3390/ijms20061473.

7.

Regulatory T Cells under the Mercy of Mitochondria.

Das M, Alzaid F, Bayry J.

Cell Metab. 2019 Feb 5;29(2):243-245. doi: 10.1016/j.cmet.2019.01.012.

PMID:
30726757
8.

Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE.

Galeotti C, Stephen-Victor E, Karnam A, Das M, Gilardin L, Maddur MS, Wymann S, Vonarburg C, Chevailler A, Dimitrov JD, Benveniste O, Bruhns P, Kaveri SV, Bayry J.

J Allergy Clin Immunol. 2019 Aug;144(2):524-535.e8. doi: 10.1016/j.jaci.2018.10.064. Epub 2018 Dec 7.

PMID:
30529242
9.

Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1.

Humbert L, Cornu M, Proust-Lemoine E, Bayry J, Wemeau JL, Vantyghem MC, Sendid B.

Front Immunol. 2018 Nov 19;9:2570. doi: 10.3389/fimmu.2018.02570. eCollection 2018. Review.

10.

Indian researchers must resist predatory open-access journals.

Bayry J.

Nature. 2018 Nov;563(7729):35. doi: 10.1038/d41586-018-07243-x. No abstract available.

PMID:
30382214
11.

Intravenous immunoglobulin protects from experimental allergic bronchopulmonary aspergillosis via a sialylation-dependent mechanism.

Bozza S, Käsermann F, Kaveri SV, Romani L, Bayry J.

Eur J Immunol. 2019 Jan;49(1):195-198. doi: 10.1002/eji.201847774. Epub 2018 Oct 29.

PMID:
30267564
12.

Kill 'Em All: Efgartigimod Immunotherapy for Autoimmune Diseases.

Bayry J, Kaveri SV.

Trends Pharmacol Sci. 2018 Nov;39(11):919-922. doi: 10.1016/j.tips.2018.08.004. Epub 2018 Sep 7. Review.

PMID:
30201270
13.

Catalytic antibodies in patients with systemic lupus erythematosus.

Pradhan V, Pandit P, Surve P, Lecerf M, Rajadhyaksha A, Nadkar M, Khadilkar PV, Chougule DA, Naigaonkar AA, Lacroix-Desmazes S, Bayry J, Ghosh K, Kaveri SV.

Eur J Rheumatol. 2018 Sep;5(3):173-178. doi: 10.5152/eurjrheum.2018.17194. Epub 2018 Aug 7.

14.

Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy.

Beziaud L, Boullerot L, Tran T, Mansi L, Marie-Joseph EL, Ravel P, Johannes L, Bayry J, Tartour E, Adotévi O.

Int J Cancer. 2018 Dec 1;143(11):3008-3018. doi: 10.1002/ijc.31842. Epub 2018 Oct 1.

PMID:
30183073
15.

Regulatory T cells induce activation rather than suppression of human basophils.

Sharma M, Das M, Stephen-Victor E, Galeotti C, Karnam A, Maddur MS, Bruneval P, Kaveri SV, Bayry J.

Sci Immunol. 2018 May 25;3(23). pii: eaan0829. doi: 10.1126/sciimmunol.aan0829.

PMID:
29802207
16.

Multimerized IgG1 Fc molecule as an anti-inflammatory agent.

Stephen-Victor E, Bayry J.

Nat Rev Rheumatol. 2018 Jul;14(7):390-392. doi: 10.1038/s41584-018-0013-9. No abstract available.

PMID:
29760434
17.

Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Fouquet G, Marcq I, Debuysscher V, Bayry J, Rabbind Singh A, Bengrine A, Nguyen-Khac E, Naassila M, Bouhlal H.

Oncotarget. 2018 Feb 26;9(22):16248-16262. doi: 10.18632/oncotarget.24575. eCollection 2018 Mar 23. Review.

18.

Induction of human dendritic cell maturation by naïve and memory B-cell subsets requires different activation stimuli.

Maddur MS, Kaveri SV, Bayry J.

Cell Mol Immunol. 2018 Dec;15(12):1074-1076. doi: 10.1038/s41423-018-0017-z. Epub 2018 Mar 22. No abstract available.

PMID:
29568116
19.

Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies.

João C, Negi VS, Kazatchkine MD, Bayry J, Kaveri SV.

J Immunol. 2018 Mar 15;200(6):1957-1963. doi: 10.4049/jimmunol.1701271. Review.

20.

Fungal melanin stimulates surfactant protein D-mediated opsonization of and host immune response to Aspergillus fumigatus spores.

Wong SSW, Rani M, Dodagatta-Marri E, Ibrahim-Granet O, Kishore U, Bayry J, Latgé JP, Sahu A, Madan T, Aimanianda V.

J Biol Chem. 2018 Mar 30;293(13):4901-4912. doi: 10.1074/jbc.M117.815852. Epub 2018 Feb 5.

21.

Role of Hydrophobins in Aspergillus fumigatus.

Valsecchi I, Dupres V, Stephen-Victor E, Guijarro JI, Gibbons J, Beau R, Bayry J, Coppee JY, Lafont F, Latgé JP, Beauvais A.

J Fungi (Basel). 2017 Dec 24;4(1). pii: E2. doi: 10.3390/jof4010002.

22.

The use of databases, data mining and immunoinformatics in vaccinology: where are we?

Hegde NR, Gauthami S, Sampath Kumar HM, Bayry J.

Expert Opin Drug Discov. 2018 Feb;13(2):117-130. doi: 10.1080/17460441.2018.1413088. Epub 2017 Dec 11. Review.

PMID:
29226722
23.

Immunotherapy as an Option for Cancer Treatment.

Rusch T, Bayry J, Werner J, Shevchenko I, Bazhin AV.

Arch Immunol Ther Exp (Warsz). 2018 Apr;66(2):89-96. doi: 10.1007/s00005-017-0491-5. Epub 2017 Oct 12. Review.

PMID:
29026920
24.

Aspergillus fumigatus Cell Wall α-(1,3)-Glucan Stimulates Regulatory T-Cell Polarization by Inducing PD-L1 Expression on Human Dendritic Cells.

Stephen-Victor E, Karnam A, Fontaine T, Beauvais A, Das M, Hegde P, Prakhar P, Holla S, Balaji KN, Kaveri SV, Latgé JP, Aimanianda V, Bayry J.

J Infect Dis. 2017 Dec 5;216(10):1281-1294. doi: 10.1093/infdis/jix469.

PMID:
28968869
25.

Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin.

Maddur MS, Kaveri SV, Bayry J.

Trends Immunol. 2017 Nov;38(11):789-792. doi: 10.1016/j.it.2017.08.008. Epub 2017 Sep 12.

PMID:
28916232
26.

Harnessing the regulators to enhance viral vaccine efficacy.

Bayry J.

Future Med Chem. 2017 Aug;9(12):1319-1321. doi: 10.4155/fmc-2017-0103. Epub 2017 Aug 3. No abstract available.

PMID:
28771039
27.

IVIG-mediated effector functions in autoimmune and inflammatory diseases.

Galeotti C, Kaveri SV, Bayry J.

Int Immunol. 2017 Dec 30;29(11):491-498. doi: 10.1093/intimm/dxx039. Review.

PMID:
28666326
28.

CCR4 is a determinant of melanoma brain metastasis.

Klein A, Sagi-Assif O, Meshel T, Telerman A, Izraely S, Ben-Menachem S, Bayry J, Marzese DM, Ohe S, Hoon DSB, Erez N, Witz IP.

Oncotarget. 2017 May 9;8(19):31079-31091. doi: 10.18632/oncotarget.16076.

29.

The Yin and Yang of regulatory T cells in infectious diseases and avenues to target them.

Stephen-Victor E, Bosschem I, Haesebrouck F, Bayry J.

Cell Microbiol. 2017 Jun;19(6). doi: 10.1111/cmi.12746. Epub 2017 Apr 26. Review.

PMID:
28382773
30.

Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN.

Saha C, Das M, Patil V, Stephen-Victor E, Sharma M, Wymann S, Jordi M, Vonarburg C, Kaveri SV, Bayry J.

Front Immunol. 2017 Mar 14;8:275. doi: 10.3389/fimmu.2017.00275. eCollection 2017.

31.

Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.

Maddur MS, Stephen-Victor E, Das M, Prakhar P, Sharma VK, Singh V, Rabin M, Trinath J, Balaji KN, Bolgert F, Vallat JM, Magy L, Kaveri SV, Bayry J.

J Neuroinflammation. 2017 Mar 20;14(1):58. doi: 10.1186/s12974-017-0818-5.

32.

Demystification of enigma on antigen-presenting cell features of human basophils: data from secondary lymphoid organs.

Stephen-Victor E, Das M, Sharma M, Galeotti C, Fohrer-Ting H, Sendid B, Darnige L, Terris B, Badoual C, Bruneval P, Kaveri SV, Bayry J.

Haematologica. 2017 Jun;102(6):e233-e237. doi: 10.3324/haematol.2016.163451. Epub 2017 Feb 16. No abstract available.

33.

Human basophils may not undergo modulation by DC-SIGN and mannose receptor-targeting immunotherapies due to absence of receptors.

Das M, Galeotti C, Stephen-Victor E, Karnam A, Kaveri SV, Bayry J.

J Allergy Clin Immunol. 2017 Apr;139(4):1403-1404.e1. doi: 10.1016/j.jaci.2016.09.062. Epub 2017 Jan 11. No abstract available.

PMID:
28088336
34.

IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to Mycobacterium tuberculosis.

Stephen-Victor E, Sharma VK, Das M, Karnam A, Saha C, Lecerf M, Galeotti C, Kaveri SV, Bayry J.

Front Immunol. 2016 Nov 4;7:465. eCollection 2016.

35.

Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the Way.

Shopsin B, Kaveri SV, Bayry J.

Cell Host Microbe. 2016 Nov 9;20(5):555-557. doi: 10.1016/j.chom.2016.10.018.

36.

Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.

Pradhan V, Pandit P, Rajadhyaksha A, Patwardhan M, Surve P, Kamble P, Lecerf M, Bayry J, Kaveri S, Ghosh K, Nadkar MY.

J Assoc Physicians India. 2016 May;64(5):14-18.

PMID:
27735143
37.

In Silico Adjuvant Design and Validation.

Davies MN, Pere H, Bosschem I, Haesebrouck F, Flahou B, Tartour E, Flower DR, Tough DF, Bayry J.

Methods Mol Biol. 2017;1494:107-125.

PMID:
27718189
38.

Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease.

Galeotti C, Kaveri SV, Cimaz R, Koné-Paut I, Bayry J.

Drug Discov Today. 2016 Nov;21(11):1850-1857. doi: 10.1016/j.drudis.2016.08.004. Epub 2016 Aug 6. Review.

PMID:
27506874
39.

Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4⁺ T Cell Responses.

Saha C, Das M, Stephen-Victor E, Friboulet A, Bayry J, Kaveri SV.

Molecules. 2016 Jul 14;21(7). pii: E912. doi: 10.3390/molecules21070912.

40.

IL-26: An Emerging Proinflammatory Member of the IL-10 Cytokine Family with Multifaceted Actions in Antiviral, Antimicrobial, and Autoimmune Responses.

Stephen-Victor E, Fickenscher H, Bayry J.

PLoS Pathog. 2016 Jun 23;12(6):e1005624. doi: 10.1371/journal.ppat.1005624. eCollection 2016 Jun. Review. No abstract available.

41.

Repressing Immunity in Autoimmune Disease.

Bayry J.

N Engl J Med. 2016 May 26;374(21):2090-2. doi: 10.1056/NEJMcibr1602864. No abstract available.

PMID:
27223152
42.

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.

Beziaud L, Mansi L, Ravel P, Marie-Joseph EL, Laheurte C, Rangan L, Bonnefoy F, Pallandre JR, Boullerot L, Gamonet C, Vrecko S, Queiroz L, Maurina T, Mouillet G, Hon TN, Curtit E, Royer B, Gaugler B, Bayry J, Tartour E, Thiery-Vuillemin A, Pivot X, Borg C, Godet Y, Adotévi O.

Cancer Res. 2016 Jul 15;76(14):4100-12. doi: 10.1158/0008-5472.CAN-15-2452. Epub 2016 May 17.

43.

Mycobacteria-responsive sonic hedgehog signaling mediates programmed death-ligand 1- and prostaglandin E2-induced regulatory T cell expansion.

Holla S, Stephen-Victor E, Prakhar P, Sharma M, Saha C, Udupa V, Kaveri SV, Bayry J, Balaji KN.

Sci Rep. 2016 Apr 15;6:24193. doi: 10.1038/srep24193.

44.

The Homophilic Domain - An Immunological Archetype.

Kohler H, Bayry J, Kaveri SV.

Front Immunol. 2016 Mar 21;7:106. doi: 10.3389/fimmu.2016.00106. eCollection 2016. Review.

45.

Relationship between natural and heme-mediated antibody polyreactivity.

Hadzhieva M, Vassilev T, Bayry J, Kaveri S, Lacroix-Desmazes S, Dimitrov JD.

Biochem Biophys Res Commun. 2016 Mar 25;472(1):281-6. doi: 10.1016/j.bbrc.2016.02.112. Epub 2016 Feb 27.

PMID:
26926563
46.

Regulatory T Cell Immunotherapy for Type 1 Diabetes: A Step Closer to Success?

Bayry J, Gautier JF.

Cell Metab. 2016 Feb 9;23(2):231-3. doi: 10.1016/j.cmet.2016.01.010.

47.

Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin.

Galeotti C, Hegde P, Das M, Stephen-Victor E, Canale F, Muñoz M, Sharma VK, Dimitrov JD, Kaveri SV, Bayry J.

Sci Rep. 2016 Jan 22;6:19592. doi: 10.1038/srep19592.

48.

Lupus pathogenesis: role of IgE autoantibodies.

Bayry J.

Cell Res. 2016 Mar;26(3):271-2. doi: 10.1038/cr.2016.12. Epub 2016 Jan 22.

49.

Chronic Chagas disease: can prophylaxis and therapeutic vaccines crack this 'hard nut'?

Bontempi I, Vicco MH, Bayry J.

Immunotherapy. 2016 Feb;8(2):99-101. doi: 10.2217/imt.15.115. Epub 2016 Jan 20. No abstract available.

50.

Impaired regulatory T cell function in autoimmune diseases: are microRNAs the culprits?

Sharma VK, Kaveri SV, Bayry J.

Cell Mol Immunol. 2016 Mar;13(2):135-7. doi: 10.1038/cmi.2015.98. Epub 2015 Dec 14. No abstract available.

Supplemental Content

Support Center